Skip to main navigation
  • About
    • Overview
    • Management
    • Board
  • Science
    • Pipeline
    • Posters & Presentations
  • Patients
    • Chronic HBV Infection
    • MASH
    • Clinical Trials
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations & Events
  • Investors
    • Overview
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Presentations & Events
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Careers
  • About
    • Overview
    • Management
    • Board
  • Science
    • Pipeline
    • Posters & Presentations
  • Patients
    • Chronic HBV Infection
    • MASH
    • Clinical Trials
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations & Events
  • Investors
    • Overview
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Presentations & Events
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Careers
Investor Relations

SEC Filing Details

Document Details

Form
SCHEDULE 13G/A
Filing Date
Aug 14, 2025
Document Date
Aug 14, 2025
Form Description
SCHEDULE 13G/A - Description
Filing Group
Other
Company
Aligos Therapeutics
Issuer
Aligos Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Print Page

Email Alerts

RSS

Investor FAQs

US OFFICE 1 Corporate Dr., 2nd Floor South San Francisco, CA 94080

EU OFFICE Gaston Geenslaan 1 / (Building 3) 3001 Leuven, Belgium

CHINA OFFICE Unit 3212, Building A, No. 100, Zunyi Road, Changning District, Shanghai, People’s Republic of China, 200051

Follow Us Linkedin Twitter info@aligos.com

© Aligos Therapeutics 2026

  • Privacy Policy
  • Terms of Service
Menu
  • About
    • Overview
    • Management
    • Board
  • Science
    • Pipeline
    • Posters & Presentations
  • Patients
    • Chronic HBV Infection
    • MASH
    • Clinical Trials
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations & Events
  • Investors
    • Overview
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Presentations & Events
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Careers